Maintaining a fit T‐cell compartment: lymphoma treatment sequencing in the era of chimeric antigen receptor T‐cell therapies

Dickinson Michael; Weinkove Robert

首页> 外文期刊>Internal medicine journal >Maintaining a fit T‐cell compartment: lymphoma treatment sequencing in the era of chimeric antigen receptor T‐cell therapies

【24h】

Maintaining a fit T‐cell compartment: lymphoma treatment sequencing in the era of chimeric antigen receptor T‐cell therapies

机译：保持拟合T细胞隔室：嵌合抗原受体T细胞疗法时代的淋巴瘤处理测序

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Internal medicine journal》 |2019年第10期|共135页
作者
Dickinson Michael; Weinkove Robert;
展开▼
作者单位

Clinical HaematologyPeter MacCallum Cancer Centre and Royal Melbourne HospitalMelbourne Victoria;

Malaghan InstituteWellington New Zealand;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词

相似文献

外文文献
中文文献
专利

1. Maintaining a fit T‐cell compartment: lymphoma treatment sequencing in the era of chimeric antigen receptor T‐cell therapies [J] . Dickinson Michael, Weinkove Robert Internal medicine journal . 2019,第10期

机译：保持拟合T细胞隔室：嵌合抗原受体T细胞疗法时代的淋巴瘤处理测序
2. Chimeric antigen receptor (CAR) T-cell therapy as a treatment option for patients with B-cell lymphomas: perspectives on the therapeutic potential of Axicabtagene ciloleucel [J] . Andreas Viardot, Verena Wais, Elisa Sala, Cancer Management and Research . 2019,第4期

机译：嵌合抗原受体（轿车）T细胞疗法作为B细胞淋巴瘤患者的治疗选择：视角于轴突的腋生虫蛋白的治疗潜力
3. Allogeneic Stem Cell Transplantation and Chimeric Antigen Receptor (CAR) T-Cell Therapy for the Treatment of Non-Hodgkin Lymphoma [J] . Hunter Bradley D., Chen Yi-Bin, Jacobson Caron A. Hematology/Oncology Clinics of North America . 2019,第4期

机译：非基因干细胞移植和嵌合抗原受体（轿厢）T细胞治疗非霍奇金淋巴瘤的治疗方法
4. Main Issues and Current Strategies in Enhancing the Efficacy of Chimeric Antigen Receptor T-Cell Therapy among Tumor Treatments [C] . Zhengting He International Conference on Frontiers of Biological Sciences and Engineering . 2020

机译：提高嵌合抗原受体T细胞治疗肿瘤治疗疗效的主要问题及目前策略
5. Targeting the Disialoganglioside GD2 with Chimeric Antigen Receptor T Cells for Immunotherapy in Diffuse Midline Gliomas, and Exploration of Neuron-OPC Synaptic Connectivity in the Context of Adaptive Myelination [D] . Mount, Christopher W. 2020

机译：用嵌合抗原受体T细胞靶向Diaialoganglioside GD2，用于在弥漫性中线胶质瘤中的免疫疗法，以及在适应性髓鞘中的背景下探索神经元-Popaptic连通性
6. Chimeric antigen receptor (CAR) T-cell therapy as a treatment option for patients with B-cell lymphomas: perspectives on the therapeutic potential of Axicabtagene ciloleucel [O] . Andreas Viardot, Verena Wais, Elisa Sala, 2019

机译：嵌合抗原受体（CAR）T细胞疗法作为B细胞淋巴瘤患者的治疗选择：Axicabtagene ciloleucel的治疗潜力的观点
7. Perceptions of community hematologists/oncologists on barriers to chimeric antigen receptor T-cell therapy for the treatment of diffuse large B-cell lymphoma [O] . Ajeet Gajra, Yolaine Jeune-Smith, Jonathan Kish, 2020

机译：对嵌合抗原受体T细胞治疗弥漫性大B细胞淋巴瘤的嵌入抗原受体T细胞疗法的障碍障碍障碍者/肿瘤科医师的看法

Maintaining a fit T‐cell compartment: lymphoma treatment sequencing in the era of chimeric antigen receptor T‐cell therapies

著录项

引文网络

相似文献

相关主题

期刊订阅